← Leaderboards
Dennis Carson
University Of California, San Diego
$26,840,334
Attributed
$26,840,334
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $7.9M · FY2014–25$10M$7.5M$5M$2.5M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,840,334 · 3
By mechanism
N01$26,840,334 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Diego
Same institution · by research overlap
- Victor Nizet$31,303,620
- Michael G Rosenfeld$73,496,650
- Liangfang Zhang$5,562,722
- Mark Joseph Walker$999,858
- Eric J Bennett$6,748,090
Others in their field
Top investigators on “Adjuvant”
- Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
- Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
- David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
- Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001
Research focus
AdjuvantCellsContractorVaccinesPathogenAnimal ModelHuman DiseaseAntigensResponseLeadB-LymphocytesStructure-Activity RelationshipHigh Throughput ScreeningT-LymphocyteAdaptive Immune SystemImmunologic MemoryAwardFormulationInnate Immune SystemProtective EfficacyImmunologic ReceptorsFda ApprovedInfluenzaExosome
Grant awards (14)
Discovery of Adjuvants for mRNA Vaccines$1,280,295
N01 · FY2025 · AI · contact PI
Discovery of Adjuvants for mRNA Vaccines$2,601,750
N01 · FY2024 · AI · contact PI
TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.$460,000
N01 · FY2024 · AI · contact PI
Discovery of agents that induce exosomes with adjuvant activity$1,445,422
N01 · FY2023 · AI · contact PI
Discovery of agents that induce exosomes with adjuvant activity$1,765,235
N01 · FY2022 · AI · contact PI
TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES.$400,000
N01 · FY2022 · AI · contact PI
Discovery of agents that induce exosomes with adjuvant activity$1,952,317
N01 · FY2021 · AI · contact PI
Discovery of agents that induce exosomes with adjuvant activity$2,073,158
N01 · FY2020 · AI · contact PI
Discovery of agents that induce exosomes with adjuvant activity$2,127,659
N01 · FY2019 · AI · contact PI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza$1,901,545
N01 · FY2018 · AI · contact PI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza$1,577,327
N01 · FY2017 · AI · contact PI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza$280,000
N01 · FY2016 · AI · contact PI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza$1,050,000
N01 · FY2015 · AI · contact PI
Adjuvant Discovery for Vaccines against West Nile Virus and Influenza$7,925,626
N01 · FY2014 · AI · contact PI